Clecell aims to provide innovative solutions in the medical field by creating artificial tissues with complex structures and functions using biomaterials and tissues. We are exploring applications in diverse fields, including patient-specific organ and tissue printing, tissue model printing for drug testing, regeneration and repair of damaged tissues, and molecular and cell biology research. These efforts have enabled Clecell to grow into a company providing innovative technologies and solutions, contributing to innovative advancements in various fields, including life sciences, healthcare, and regenerative medicine.
Clecell’s vision is to use innovative 3D bioprinting technology to create various biological tissues, including artificial skin and organoids, and to become a leader in regenerative medicine. Clecell, Inc. strives to become a global company that improves people’s lives and contributes to the treatment of diseases through life science technologies, and to pursue research and innovation for a sustainable future.